SEC Form 4 · accession 0001193125-26-371548
Hinge Health, Inc. · HNGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Elliott Robinson
Director
Period of report
Aug 25, 2026
Accepted (ET)
Aug 27, 2026 · 5:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001673743
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2 | Aug 25, 2026 | S$0 | 0 | $0.00 | D | 0 | I | See footnote |
| Class A Common StockF1,F2,F3 | Aug 26, 2026 | S$0 | 0 | $0.00 | D | 0 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F2The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
- F3On August 26, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 58,484 and 55,243 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.71. These shares were sold in multiple transactions at prices ranging from $91.20 to $92.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.